+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osmotica Pharmaceutical Corporation - logo

Osmotica pharmaceutical company is renowned for its creation of branded and generic products.They were created as a spin off company from ‘Phoenix’ in 2000 focusing solely on new ways for drug delivery. They created their proprietary osmotic technology platform. These products are therapeutical drugs designed to treat movement disorders such as MS and Parkinson’s disease.Through their subsidiaries ‘Vertical Pharmaceuticals’ and ‘Trigen Laboratories’ they have the ability to commercialize their new products rapidly. They are an international company with their main operations located in the United States, Hungary and Argentina.

OTC Probiotics Supplement Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

OTC Probiotics Supplement Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 148 Pages
  • Global
From
OTC Probiotics Supplements Market - Forecasts from 2020 to 2025 - Product Thumbnail Image

OTC Probiotics Supplements Market - Forecasts from 2020 to 2025

  • Report
  • August 2020
  • 120 Pages
  • Global
From
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 500 Pages +
  • Global
From
Acquired Blepharoptosis - Pipeline Insight, 2024 - Product Thumbnail Image

Acquired Blepharoptosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Muscle Spasticity - Pipeline Insight, 2024 - Product Thumbnail Image

Muscle Spasticity - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
GABAB Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

GABAB Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
  • 17 Results (Page 1 of 1)
Loading Indicator